Kendle International Inc.
441 Vine Street
Suite 500
Cincinnati,
OH 45202
United States - Map
Phone: 513-381-5550
Fax: 513-381-5870
Web Site: http://www.kendle.com
| Kendle International Inc., a clinical research organization, provides clinical development services on a contract basis to the biopharmaceutical industry worldwide. The companys clinical development services include clinical trial management, clinical data management, statistical analysis, medical writing, regulatory consulting and organizational meeting management, and publications services. It operates through two segments, Early Stage and Late Stage. The Early Stage segment focuses on its Phase I operations. The Late Stage segment comprises clinical development services related to Phase II through III clinical trials; late phase clinical development services related to Phase IIIB and IV clinical trials. It also provides regulatory expertise and consulting services at various stages of drug and device development; designs clinical programs and clinical trial protocols, reviews programs, and provides gap analysis; offers consulting services for nonclinical development for small molecules, biologicals, vaccines, and devices; assists in the U.S. Food and Drug Administration application process; and involves in collection, analysis, and reporting of drug safety data. In addition, this segment offers customized clinical data management with the ability to connect into and utilize a customers own data systems. Kendle International operates in North America, Europe, Asia/Pacific, Latin America, and Africa. The company was founded in 1981 and is based in Cincinnati, Ohio. |
|
| Key Statistics |
| |
| | Pay | Exercised | Dr. Candace Kendle , 62
Chairman and Chief Exec. Officer |
$
665.00K |
$
790.00K | Mr. Christopher C. Bergen MBA, 58
Chief Admin. Officer and Exec. VP |
$
470.00K |
$
790.00K | Mr. Simon S. Higginbotham , 48
Chief Marketing Officer and Sr. VP |
$
387.00K |
$
0 | Mr. Keith A. Cheesman , 50
Chief Financial Officer and Sr. VP |
N/A
| N/A | Dr. Stephen A. Cutler Ph.D., MBA, 49
Chief Operating Officer and Sr. VP |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
2.03% Nasdaq 0.00%
Profile
